Economic Feasibility Test definition

Economic Feasibility Test means the test to determine whether capital expenditure is conforming capital expenditure as constituted by Rule 79(1)(a) and 79(2)(a) or 79(2)(b) of the National Gas Rules.
Economic Feasibility Test means, subject to section 8.16(a) of the Victorian Access Code, that the Anticipated Incremental Revenue generated by the New Facility exceeds the New Facilities Investment;
Economic Feasibility Test means that the Anticipated Incremental Revenue generated by the New Facility exceeds the New Facilities Investment.

Examples of Economic Feasibility Test in a sentence

  • This Service includes the operation and maintenance of Connection assets being Expansions or Extensions comprising work on the Main, service pipe and metering Installation and scheduled meter reading.MG will subject the costs of the Connection assets for Residential Haulage Reference Services to an Economic Feasibility Test as set out in the Extension and Expansions Policy detailed in section 5.5 of Part A of MG’s Access Arrangement.

  • Meter connections are subject to an Economic Feasibility Test based on agreement between all parties involved; negotiation should take place at the first gas supply request.

  • This Service includes the operation and maintenance of Connection assets (being Expansions or Extensions comprising work on the Main, service pipe and metering Installation) and scheduled meter reading services.Multinet Gas will subject the costs of the Connection assets for Non-Residential Tariff V Haulage Reference Services to an Economic Feasibility Test as set out in the Extension and Expansions Policy detailed in section 5.5 of Part A of Multinet Gas’s Access Arrangement.

  • This Service includes the operation and maintenance of Connection assets (being Expansions or Extensions comprising work on the Main, service pipe and metering Installation) and scheduled meter reading services.MG will subject the costs of the Connection assets for Non-Residential Tariff V Haulage Reference Services to an Economic Feasibility Test as set out in the Extension and Expansions Policy detailed in section 5.5 of Part A of MG’s Access Arrangement.

  • Subject to a Market Competitiveness Check, an Economic Feasibility Test and the terms of any applicable Spectrum Acquisition Agreement, QSI or its Affiliates may provide, at QSI’s option exercised in its sole discretion, Service Delivery either directly or managed programmatically using subcontractors as part of the Construction Services in a Starry Market.

  • Under the Extensions/Expansions Policy, the standard procedure for new facilities that do not satisfy the Economic Feasibility Test is to recover the capital cost by means of a surcharge or capital contribution.

  • IRPA DCF+ Review and Analysis Appendix A – Three-stage Economic Feasibility Test – Stage 3 CalculationsAppendix A1 - EB-2019-0183 (Owen Sound Reinforcement)65The economic benefits for Ontario were estimated to be $71M.

  • Envestra has been rigorous in its application of the Economic Feasibility Test, individually assessing each investment.

  • Economic Feasibility Test: If the estimated cost of rehabilitation is greater than 75% of the estimated repaired value of the dwelling, it shall be determined that rehabilitation is not economically feasible.


More Definitions of Economic Feasibility Test

Economic Feasibility Test means determining grounds for issuing permits based on the economic feasibility or market demand, assessment of the potential or existing business or economic impact of respective activities or assessment of compliance of the activities with economic planning objectives set by the competent authority. This term shall not include any conditions associated with non-economic planning and based on the grounds of public interest, such as social policy, implementation of socio-economic development programs approved by local authorities within their competence, or protection of the urban environment, including implementation of urban development plans;

Related to Economic Feasibility Test

  • S&P CDO Monitor Test A test that will be satisfied on any date of determination (following receipt, at any time on or after the S&P CDO Monitor Election Date, by the Issuer and the Collateral Administrator of the Class Break-even Default Rates for each S&P CDO Monitor input file (in accordance with the definition of “Class Break-even Default Rate”)) if, after giving effect to a proposed sale or purchase of an additional Collateral Obligation, the Class Default Differential of the Highest Ranking Class of the Proposed Portfolio is positive. The S&P CDO Monitor Test will be considered to be improved if the Class Default Differential of the Proposed Portfolio that is not positive is greater than the corresponding Class Default Differential of the Current Portfolio.

  • COVID-19 test means a viral test for SARS-CoV-2 that is:

  • Percolation test means a subsurface soil test at the depth of a proposed absorption system or similar component of an OWTS to determine the water absorption capability of the soil, the results of which are normally expressed as the rate at which one inch of water is absorbed. The rate is expressed in minutes per inch.

  • Feasibility Study means the evaluation and analysis of the potential of a project, which aims at supporting the process of decision-making by objectively and rationally uncovering its strengths and weaknesses, opportunities and threats, as well as identifying the resources required to carry it through and ultimately its prospects for success;

  • Collateral Quality Test means a test that is satisfied if, as of any date of determination, in the aggregate, the Collateral Loans owned (or in relation to a proposed acquisition of a Collateral Loan, both owned and proposed to be owned) by the Borrower satisfy each of the tests set forth below, calculated in each case in accordance with Section 1.3:

  • Collateral Quality Tests means the Collateral Quality Tests set out in the Investment Management Agreement being each of the following:

  • Penetration Testing means security testing in which assessors mimic real-world attacks to identify methods for circumventing the security features of an application, system, or network. (NIST SP 800-115)

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Performance Test means all operational checks and tests required to determine the performance parameters including inter-alia capacity, efficiency and operating characteristics of the Stores as specified in the Contract.

  • Asset Test means, for an Asset Review, each Test, as defined in the Asset Representations Review Agreement, in Schedule A to the Asset Representations Review Agreement to be performed by the Asset Representations Reviewer on the related Asset Review Receivables.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Performance Tests means the tests to be conducted on the equipment at site for checking the performance parameters of the equipment as defined in Technical Specification.

  • ASAM criteria means admission, continued service, transfer, and discharge criteria for the treatment of substance use disorders as published by the American Society of Addiction Medicine (ASAM).

  • Evaluation Criteria means the criteria set out under the clause 27 (Evaluation Process) of this Part C, which includes the Qualifying Criteria, Functional Criteria and Price and Preferential Points Assessment.

  • Sales assessment ratio studies means sales assessment ratio studies

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Corrective Measure means a measure as defined in Article 3, point 16, of Regulation (EU) 2019/1020;

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Fit test means the use of a protocol to qualitatively or quantitatively evaluate the fit of a respirator on an individual.

  • EPP test Means one EPP command sent to a particular “IP address” for one of the EPP servers. Query and transform commands, with the exception of “create”, shall be about existing objects in the Registry System. The response shall include appropriate data from the Registry System. The possible results to an EPP test are: a number in milliseconds corresponding to the “EPP command RTT” or undefined/unanswered.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Screening Test means a drug or alcohol test which uses a method of analysis allowed by the Minnesota Drug and Alcohol Testing in the Workplace Act to be used for such purposes.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.